text
stringlengths 1
2.37k
|
|---|
36 Subjects with compliance ≥80% at week 4, n (%) 66 (100.
|
Moon SJ, Jeon J-Y, Jang K, et al.
|
7 mm Hg in the valsartan group, respectively.
|
To compare categorical variables, chi-square test was used.
|
4 82.
|
TA B LE 3 Change from baseline in MSSBP and LDL-C at week 4 and week 8 Tel/Aml 80/5 mg + Ros 20 mg (N = 66) Tel/Aml 80/5 mg (N = 66) Tel80 mg + Ros20 mg (N = 65) MSSBP (mm Hg) Baseline 155.
|
The change in the absorption phase of rosuvastatin is evident with a shortened Tmax,ss, and the mechanism of this change was speculated to be due to intervention in hepatic uptake and a possible change to biliary excretion transporters.
|
3 80.
|
38.
|
23) mm Hg, −7.
|
23.
|
More recently, another meta-analysis of 8 randomized controlled clinical trials and 433 participants with diabetes found that cocoa consumption exerts a significant reduction in LDL-C levels (SMD: – 15.
|
2019.
|
10–1.
|
Lancet.
|
Antihypertensive Interventions After registration, potentially eligible patients entered a 2-week run-in period and discontinued any antihypertensive medications.
|
J Hypertens 2005; 23: 1617-1631.
|
5 93.
|
9 44.
|
Mean BP was calculated from the last two of the three or more measured BPs.
|
58.
|
The evidence on the BP-lowering effect in humans following supplementation with berberine is less solid and limit to single small clinical trials.
|
Berberine supplementation was effective in improving serum levels of total cholesterol (TC: – 0.
|
5 mg plus amiloride/hydrochlorothiazide 1.
|
77 ± 36.
|
69 ± 1.
|
36 3.
|
9908 (0.
|
34 153.
|
2019 ESC/ EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
|
Ju J, Li J, Lin Q, Xu H.
|
46.
|
1002/ ptr.
|
9) 845 (29.
|
92) 1.
|
Our findings of an association between low HDLC levels and an increased risk of hypertension are consistent with previous reports.
|
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.
|
13 (1.
|
5.
|
57–1.
|
Effects of age, gender and statin dose on lipid levels: Results from the VOYAGER meta-analysis database.
|
org/ 10.
|
However, after adjustment for potential confounders, these differences were smaller and the effect size on HDL-C for users of both beta-blocker and diuretic only persisted [57].
|
3 5.
|
022 Non-HDLC, mg/dL 25 to 105 106 to 123 124 to 140 141 to 162 163 to 334 No.
|
09 0.
|
17 88.
|
89 47.
|
Am J Ther 2003; 10(6):409–414.
|
Data from our study also confirm the results of previous studies that examined the effects of various antihypertensive agents on serum lipid parameters.
|
868±0.
|
4198) for AUCτ,ss.
|
Catena C, Novello M, Lapenna R, et al: New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein (a).
|
3 Smokers (%) 26.
|
00 ± 12.
|
77–2.
|
2014;27(7):885–96.
|
32 1.
|
27 (1.
|
S.
|
9) 257 (8.
|
Ross R.
|
Co.
|
0 150.
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.